Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption.
Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice.
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19.
Ubiquitination and SUMOylation in HIV Infection: Friends and Foes.
Pan-resistant HIV-1 emergence in the era of integrase strand-transfer inhibitors: a case report.
Potential prescribing issues among older HIV-infected persons in a Mediterranean cohort: Does the current prevalence give cause for concern?
Use of antiviral drugs to reduce COVID-19 transmission.